跳至主要内容
临床试验/EUCTR2017-002095-10-DK
EUCTR2017-002095-10-DK进行中(未招募)1 期

Investigate the differences between treating Chronic Kidney Disease - Mineral and Bone Disorder with an iron-containing phosphate binder or a calcium-containing phosphate binder in Chronic Kidney Disease stage 3-5. - MIVI

niversitetsklinik for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro; Hospitalsenheden Vest0 个研究点目标入组 35 人开始时间: 2017年6月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 35-65 years old men and women with 3-5 CKD and requiring treatment for hyperphosphatemia
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Inability to give informed consent, pregnancy, lactation, not radically treated cancer, alcohol abuse or drug abuse. Within three months: fractures, AMI, TCI, kidney transplant or parathyroidectomy.

研究者

发起方
niversitetsklinik for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro; Hospitalsenheden Vest

相似试验

Investigate the differences between treating Chronic... | 临床试验